About the Product

Description


Epihype 50 Tablet containing Eperisone is used for the management of muscle spasms and musculoskeletal pain. It helps in relieving stiffness, reducing discomfort, and improving movement.

Eperisone works by relaxing skeletal muscles and improving blood circulation, which helps in reducing muscle tightness and associated pain.

The tablet is widely prescribed in orthopedic and general practice for back pain, neck pain, and muscle stiffness, leading to consistent demand and repeat usage.

With increasing cases of musculoskeletal disorders and demand for effective muscle relaxants, this product offers strong business potential for retailers and distributors. Its regular prescription flow, broad usage, and consistent demand make it a fast-moving product that can drive steady sales and growth in the orthopedic segment.

Some patients may experience dizziness, drowsiness, nausea, or weakness. Rarely, allergic reactions or gastrointestinal discomfort may occur and require medical attention.

Epihype 50 Tablet is indicated for the management of muscle spasms, back pain, cervical pain, and other musculoskeletal conditions associated with stiffness and discomfort. It helps relax muscles, reduce pain, and enhance physical movement.

This medicine should be used under medical supervision. It may cause drowsiness, so caution is advised while driving or operating machinery. Patients with liver disorders should consult their healthcare provider before use.

Store in a cool, dry place below 25°C, protected from moisture and direct sunlight. Keep the tablets in their original packaging and out of reach of children.

Get in Touch

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions

What are the business opportunities for Epihype 50 Tablet in the PCD pharma franchise market?

Epihype 50 Tablet, containing Eperisone 50mg, has strong demand in the muscle relaxant and orthopedic segment, making it a profitable product for medical distributors, wholesalers, and pharma franchise partners focusing on musculoskeletal and pain management portfolios.

Why should medical distributors include Epihype 50 Tablet in their product range?

Medical distributors and agencies can benefit from the consistent market demand for muscle relaxants used in muscle spasm, cervical pain, back pain, and neuromuscular conditions. Epihype 50 Tablet helps strengthen a focused musculoskeletal care product portfolio.

Does Cafoli LifeCare Pvt Ltd offer PCD pharma franchise opportunities for Epihype 50 Tablet?

Yes, Cafoli LifeCare Pvt Ltd offers PCD pharma franchise opportunities for Epihype 50 Tablet with promotional support, monopoly rights, quality packaging, and competitive pricing for distributors and wholesalers.

What benefits do wholesalers get by partnering for Epihype 50 Tablet distribution?

Wholesalers and medical agencies benefit from attractive business margins, reliable product availability, professional support, and access to a trusted muscle relaxant product range when partnering for Epihype 50 Tablet distribution.

How can I become a distributor or franchise partner for Epihype 50 Tablet?

Medical distributors, stockists, and wholesalers interested in Epihype 50 Tablet can contact Cafoli LifeCare Pvt Ltd to discuss franchise opportunities, bulk supply requirements, pricing, and distribution support.